2 days ago
WGS
AnalystsSubbu NambiSubbu Nambi's Stock Forecasts
AnalystsSubbu Nambi
Analyst Ranking
Top 2%
#63 out of 5312 analysts
Average Return
+103.34%
Win Rate
65%53 out of 82
Risk vs Reward
Poor
Good
Subbu Nambi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +4,095.93% | $44.45 | $1,865.09 | 2025-04-11 - 2026-03-24 | Strong Buy |
Exact Sciences CorpEXAS | +2,580.11% | $69.59 | $1,865.09 | 2025-11-04 - 2026-03-24 | Strong Buy |
Natera IncNTRA | +176.34% | $60.27 | $166.55 | 2023-12-14 - 2024-12-13 | Strong Buy |
Guardant Health IncGH | +149.30% | $60.18 | $150.03 | 2025-09-25 - 2026-06-30 | Strong Buy |
Twist Bioscience CorpTWST | +142.30% | $42.46 | $102.88 | 2026-01-26 - 2026-06-30 | Strong Buy |
Subbu Nambi Analyst Color
Get additional color on Subbu Nambi's coverage of popular stocks
2 days ago
VCYT
2 days ago
TWST
2 days ago
NTRA
2 days ago
GH
2 days ago
BLLN
2 days ago
ADPT
2 months ago
BLLN
2 months ago
TWST
2 months ago
CYRX
3 months ago
TWST
4 months ago
NAUT
5 months ago
TWST
5 months ago
SOPH
5 months ago
PSNL
5 months ago
GRAL
5 months ago
GH
5 months ago
CSTL
5 months ago
ADPT
6 months ago
VCYT
6 months ago
NTRA
6 months ago
GH
6 months ago
DHR
6 months ago
CSTL
8 months ago
PSNL
Subbu Nambi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Genedx Holdings CorpWGS | 5 | Strong Buy | $74.00 | +7.79% | Maintains | 2 days ago |
Veracyte IncVCYT | 7 | Strong Buy | $65.00 | +10.68% | Maintains | 2 days ago |
Twist Bioscience CorpTWST | 6 | Strong Buy | $107.00 | +4.00% | Maintains | 2 days ago |
Natera IncNTRA | 4 | Strong Buy | $290.00 | +6.83% | Maintains | 2 days ago |
Illumina IncILMN | 7 | Strong Buy | $200.00 | +13.75% | Maintains | 2 days ago |
Guardant Health IncGH | 6 | Strong Buy | $160.00 | +6.65% | Maintains | 2 days ago |
Bruker CorpBRKR | 5 | Strong Buy | $70.00 | +16.32% | Maintains | 2 days ago |
Billiontoone IncBLLN | 4 | Strong Buy | $125.00 | +4.18% | Initiates Coverage On | 2 days ago |
Adaptive Biotechnologies CorpADPT | 4 | Strong Buy | $22.00 | +2.56% | Maintains | 2 days ago |
Cryoport IncCYRX | 2 | Strong Buy | $12.00 | -23.57% | Maintains | 2 months ago |
Danaher CorpDHR | 4 | Strong Buy | $235.00 | +23.37% | Maintains | 2 months ago |
Grail IncGRAL | 3 | Strong Buy | $75.00 | +9.86% | Maintains | 3 months ago |
Tempus Ai IncTEM | 4 | Strong Buy | $60.00 | +3.57% | Maintains | 3 months ago |
Nautilus Biotechnology IncNAUT | 2 | Strong Buy | $4.00 | +113.90% | Maintains | 4 months ago |
Waters CorpWAT | 1 | Strong Buy | $440.00 | +17.32% | Reiterates | 5 months ago |
Sophia Genetics SaSOPH | 2 | Strong Buy | $7.00 | +21.32% | Maintains | 5 months ago |
Personalis IncPSNL | 2 | Strong Buy | $13.00 | -2.99% | Maintains | 5 months ago |
Castle Biosciences IncCSTL | 3 | Strong Buy | $47.00 | +97.06% | Maintains | 5 months ago |
Neogen CorpNEOG | 4 | Strong Buy | $12.00 | +33.48% | Maintains | 6 months ago |
Exact Sciences CorpEXAS | 3 | Strong Buy | $75.00 | -95.98% | Maintains | 8 months ago |
Caris Life Sciences IncCAI | 2 | Strong Buy | $36.00 | +102.02% | Maintains | a year ago |
Myriad Genetics IncMYGN | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
10x Genomics IncTXG | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.